To DF/HCC Members,
As an NCI-designated Comprehensive Cancer Center, we are required to have an ongoing scientific review process for all active protocols. Accordingly, I would like to let you know about a new committee for scientific progress review that will begin to meet on April 17, 2008. This new process, which is different from IRB continuing review, will be led by Jim Griffin.
The Scientific Progress Review Committee will review trials annually based on accrual data, the results of the IRB continuing review, and prioritization information from Program Leaders. It will also assume the functions of the former accrual monitoring committee.
We are working to make this process as simple as possible for your study teams. If you have any questions, please contact Jane Russell at (617) 632-3764.
Edward J. Benz Jr., MD